Bipolar Disorder Biobank Overview

The Individualized Medicine Biobank for Bipolar Disorder is intended to serve as a resource for the bipolar research community. This biobank will be open to collaborations after a three-year infrastructure development.

Researchers are establishing a large-scale biobank of Bipolar Type I and II Disorder, collecting both biologic samples and clinical data from 2,000 individuals ages 18-80. This is a multi-site endeavor, with Mayo Clinic Minnesota serving as the primary project site. Researchers at Mayo Clinic will collaborate with other researchers at the University of Minnesota, Lindner Center of Hope (Cincinnati, Ohio) as well as the Mayo Clinic sites of Arizona and Florida.

We are also collaborating with the Mayo Health System, including Austin Medical Center. By establishing the infrastructure of this data-rich biobank, researchers hope to facilitate studies on disease risk and pharmacogenomic probes utilizing state-of-the-art research technology.

Read more about the Bipolar Disorder Biobank